title: [Liver allografts from donors older than 60: benefits and risks].
abstract: With limited organ resources and an increasing number of candidates for liver transplantation, the world-wide trend is towards using liver allografts from donors older than 60 years. This strategy, however, may be hazardous because of the known correlation between advanced donor age and graft dysfunction. Since January 1996, each of 5 patients received a liver allograft from a donor older than 60 years. Preservation time in these cases was shortened as much as possible and liver allografts were used only if there were no other potential risk factors for primary nonfunction. Mean cold ischemic time was significantly shorter in this donor group (7.8 hrs) than for livers from 28 younger donors (10.2 hour; p < 0.01). 3 of the 5 grafts from older donors had normal function immediately. The other 2 initially had biochemical features of preservation injury, but graft function returned to normal within the first week after transplantation. All 5 patients currently have normal graft function, with follow-up ranging from 3-8 months. There was no difference between the 5 recipients of grafts from older donors and 28 adult recipients of grafts from younger donors in extent of preservation injury and in immediate graft function. We conclude that in countries with limited organ resources, such as Israel, liver allografts from older donors can be used within defined limits and minimal preservation time.
authors.affiliation: Transplantation Dept., Rabin Medical Center.
authors.forename: E
authors.initials: E
authors.lastname: Mor
authors.forename: D
authors.initials: D
authors.lastname: Shmueli
authors.forename: Z
authors.initials: Z
authors.lastname: Ben-Ari
authors.forename: N
authors.initials: N
authors.lastname: Bar-Nathan
authors.forename: E
authors.initials: E
authors.lastname: Sharabani
authors.forename: A
authors.initials: A
authors.lastname: Yussim
authors.forename: B
authors.initials: B
authors.lastname: Dorfman
authors.forename: R
authors.initials: R
authors.lastname: Tur-Kaspa
authors.forename: Z
authors.initials: Z
authors.lastname: Shapira
mesh_terms: D000328:Adult; D000367:Age Factors; D005500:Follow-Up Studies; D006801:Humans; D016031:Liver Transplantation / Q000502:physiology; D008875:Middle Aged; D009926:Organ Preservation; D014019:Tissue Donors; D014184:Transplantation, Homologous; D016896:Treatment Outcome